Shinde Rahul, Shimoda Michiko, Chaudhary Kapil, Liu Haiyun, Mohamed Eslam, Bradley Jillian, Kandala Sridhar, Li Xia, Liu Kebin, McGaha Tracy L
Cancer Immunology, Inflammation, and Tolerance, Cancer Center, Georgia Regents University, Augusta, GA 30912;
Cancer Signaling and Angiogenesis Programs, Cancer Center, Georgia Regents University, Augusta, GA 30912; and.
J Immunol. 2015 Sep 1;195(5):2374-82. doi: 10.4049/jimmunol.1402854. Epub 2015 Jul 27.
Humoral responses to nonproteinaceous Ags (i.e., T cell independent [TI]) are a key component of the early response to bacterial and viral infection and a critical driver of systemic autoimmunity. However, mechanisms that regulate TI humoral immunity are poorly defined. In this study, we report that B cell-intrinsic induction of the tryptophan-catabolizing enzyme IDO1 is a key mechanism limiting TI Ab responses. When Ido1(-/-) mice were immunized with TI Ags, there was a significant increase in Ab titers and formation of extrafollicular Ab-secreting cells compared with controls. This effect was specific to TI Ags, as Ido1 disruption did not affect Ig production after immunization with protein Ags. The effect of IDO1 abrogation was confined to the B cell compartment, as adoptive transfer of Ido1(-/-) B cells to B cell-deficient mice was sufficient to replicate increased TI responses observed in Ido1(-/-) mice. Moreover, in vitro activation with TLR ligands or BCR crosslinking rapidly induced Ido1 expression and activity in purified B cells, and Ido1(-/-) B cells displayed enhanced proliferation and cell survival associated with increased Ig and cytokine production compared with wild-type B cells. Thus, our results demonstrate a novel, B cell-intrinsic, role for IDO1 as a regulator of humoral immunity that has implications for both vaccine design and prevention of autoimmunity.
对非蛋白质抗原(即T细胞非依赖[TI]抗原)的体液免疫反应是对细菌和病毒感染早期反应的关键组成部分,也是系统性自身免疫的关键驱动因素。然而,调节TI体液免疫的机制尚不清楚。在本研究中,我们报告色氨酸分解代谢酶IDO1的B细胞内源性诱导是限制TI抗体反应的关键机制。用TI抗原免疫Ido1(-/-)小鼠时,与对照组相比,抗体滴度显著增加,且形成了滤泡外抗体分泌细胞。这种效应是TI抗原特有的,因为Ido1基因敲除并不影响用蛋白质抗原免疫后的Ig产生。IDO1缺失的效应局限于B细胞区室,因为将Ido1(-/-) B细胞过继转移到B细胞缺陷小鼠足以重现Ido1(-/-)小鼠中观察到的增强的TI反应。此外,用TLR配体或BCR交联进行体外激活可迅速诱导纯化B细胞中Ido1的表达和活性,与野生型B细胞相比,Ido1(-/-) B细胞表现出与Ig和细胞因子产生增加相关的增强的增殖和细胞存活。因此,我们的结果证明了IDO1作为体液免疫调节剂的一种新的、B细胞内源性的作用,这对疫苗设计和自身免疫的预防都有影响。